Biology of Tenascin C and its Role in Physiology and Pathology
- Authors: Abedsaeidi M.1, Hojjati F.2, Tavassoli A.3, Sahebkar A.4
-
Affiliations:
- Department of Basic Sciences, Faculty of Veterinary Medicine,, Ferdowsi University of Mashhad
- Division of Industrial and Environmental Biotechnology,, National Institute of Genetic Engineering and Biotechnology
- Division of Biotechnology, Ferdowsi University of Mashhad
- Biotechnology Research Center, Pharmaceutical Technology Institute,, Mashhad University of Medical Sciences
- Issue: Vol 31, No 19 (2024)
- Pages: 2706-2731
- Section: Anti-Infectives and Infectious Diseases
- URL: https://rjmseer.com/0929-8673/article/view/644577
- DOI: https://doi.org/10.2174/0929867330666230404124229
- ID: 644577
Cite item
Full Text
Abstract
Tenascin-C (TNC) is a multimodular extracellular matrix (ECM) protein hexameric with several molecular forms (180-250 kDa) produced by alternative splicing at the pre-mRNA level and protein modifications. The molecular phylogeny indicates that the amino acid sequence of TNC is a well-conserved protein among vertebrates. TNC has binding partners, including fibronectin, collagen, fibrillin-2, periostin, proteoglycans, and pathogens. Various transcription factors and intracellular regulators tightly regulate TNC expression. TNC plays an essential role in cell proliferation and migration. Unlike embryonic tissues, TNC protein is distributed over a few tissues in adults. However, higher TNC expression is observed in inflammation, wound healing, cancer, and other pathological conditions. It is widely expressed in a variety of human malignancies and is recognized as a pivotal factor in cancer progression and metastasis. Moreover, TNC increases both pro-and anti-inflammatory signaling pathways. It has been identified as an essential factor in tissue injuries such as damaged skeletal muscle, heart disease, and kidney fibrosis. This multimodular hexameric glycoprotein modulates both innate and adaptive immune responses regulating the expression of numerous cytokines. Moreover, TNC is an important regulatory molecule that affects the onset and progression of neuronal disorders through many signaling pathways. We provide a comprehensive overview of the structural and expression properties of TNC and its potential functions in physiological and pathological conditions.
Keywords
About the authors
Malihehsadat Abedsaeidi
Department of Basic Sciences, Faculty of Veterinary Medicine,, Ferdowsi University of Mashhad
Email: info@benthamscience.net
Farzaneh Hojjati
Division of Industrial and Environmental Biotechnology,, National Institute of Genetic Engineering and Biotechnology
Email: info@benthamscience.net
Amin Tavassoli
Division of Biotechnology, Ferdowsi University of Mashhad
Email: info@benthamscience.net
Amirhossein Sahebkar
Biotechnology Research Center, Pharmaceutical Technology Institute,, Mashhad University of Medical Sciences
Author for correspondence.
Email: info@benthamscience.net
References
- Giblin, S.P.; Midwood, K.S. Tenascin-C: Form versus function. Cell Adhes. Migr., 2015, 9(1-2), 48-82. doi: 10.4161/19336918.2014.987587 PMID: 25482829
- Lowy, C.M.; Oskarsson, T. Tenascin C in metastasis: A view from the invasive front. Cell Adhes. Migr., 2015, 9(1-2), 112-124. doi: 10.1080/19336918.2015.1008331 PMID: 25738825
- Midwood, K.S.; Chiquet, M.; Tucker, R.P.; Orend, G. Tenascin-C at a glance. J. Cell Sci., 2016, 129(23), 4321-4327. PMID: 27875272
- Midwood, K.S.; Orend, G. The role of tenascin-C in tissue injury and tumorigenesis. J. Cell Commun. Signal., 2009, 3(3-4), 287-310. doi: 10.1007/s12079-009-0075-1 PMID: 19838819
- Chiquet, M.; Fambrough, D.M. Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J. Cell Biol., 1984, 98(6), 1926-1936. doi: 10.1083/jcb.98.6.1926 PMID: 6725406
- Chiquet-Ehrismann, R.; Matsuoka, Y.; Hofer, U.; Spring, J.; Bernasconi, C.; Chiquet, M. Tenascin variants: Differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul., 1991, 2(11), 927-938. doi: 10.1091/mbc.2.11.927 PMID: 1725601
- Udalova, I.A.; Ruhmann, M.; Thomson, S.J.; Midwood, K.S. Expression and immune function of tenascin-C. Crit. Rev. Immunol., 2011, 31(2), 115-145. doi: 10.1615/CritRevImmunol.v31.i2.30
- Zuliani-Alvarez, L.; Marzeda, A.M.; Deligne, C.; Schwenzer, A.; McCann, F.E.; Marsden, B.D.; Piccinini, A.M.; Midwood, K.S. Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers. Nat. Commun., 2017, 8(1), 1595. doi: 10.1038/s41467-017-01718-7 PMID: 29150600
- Yokosaki, Y.; Monis, H.; Chen, J.; Sheppard, D. Differential effects of the integrins α9β1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the β subunit extracellular and cytoplasmic domains. J. Biol. Chem., 1996, 271(39), 24144-24150. doi: 10.1074/jbc.271.39.24144 PMID: 8798654
- Midwood, K.; Sacre, S.; Piccinini, A.M.; Inglis, J.; Trebaul, A.; Chan, E.; Drexler, S.; Sofat, N.; Kashiwagi, M.; Orend, G.; Brennan, F.; Foxwell, B. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med., 2009, 15(7), 774-780. doi: 10.1038/nm.1987 PMID: 19561617
- Nikoloudaki, G. Functions of matricellular proteins in dental tissues and their emerging roles in orofacial tissue development, maintenance, and disease. Int. J. Mol. Sci., 2021, 22(12), 6626. doi: 10.3390/ijms22126626 PMID: 34205668
- Okada, T.; Suzuki, H. The role of tenascin-C in tissue injury and repair after stroke. Front. Immunol., 2021, 11, 607587. doi: 10.3389/fimmu.2020.607587 PMID: 33552066
- Fujimoto, N.; Onishi, K.; Sato, A.; Terasaki, F.; Tsukada, B.; Nozato, T.; Yamada, T.; Imanaka-Yoshida, K.; Yoshida, T.; Ito, M.; Hiroe, M. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure. J. Card. Fail., 2009, 15(10), 898-905. doi: 10.1016/j.cardfail.2009.06.443 PMID: 19944367
- Bourdon, M.A.; Wikstrand, C.J.; Furthmayr, H.; Matthews, T.J.; Bigner, D.D. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res., 1983, 43(6), 2796-2805. PMID: 6342760
- Erickson, H.P.; Inglesias, J.L. A six-armed oligomer isolated from cell surface fibronectin preparations. Nature, 1984, 311(5983), 267-269. doi: 10.1038/311267a0 PMID: 6482952
- Kruse, J.; Keilhauer, G.; Faissner, A.; Timpl, R.; Schachner, M. The J1 glycoproteina novel nervous system cell adhesion molecule of the L2/HNK-1 family. Nature, 1985, 316(6024), 146-148. doi: 10.1038/316146a0 PMID: 2409452
- Grumet, M.; Hoffman, S.; Chuong, C.M.; Edelman, G.M. Polypeptide components and binding functions of neuron-glia cell adhesion molecules. Proc. Natl. Acad. Sci., 1984, 81(24), 7989-7993. doi: 10.1073/pnas.81.24.7989 PMID: 6393132
- Erickson, H.P.; Taylor, H.C. Hexabrachion proteins in embryonic chicken tissues and human tumors. J. Cell Biol., 1987, 105(3), 1387-1394. doi: 10.1083/jcb.105.3.1387 PMID: 3654758
- Chiquet-Ehrismann, R.; Mackie, E.J.; Pearson, C.A.; Sakakura, T. Tenascin: An extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell, 1986, 47(1), 131-139. doi: 10.1016/0092-8674(86)90374-0 PMID: 2428505
- Tucker, R.P.; Chiquet-Ehrismann, R. Evidence for the evolution of tenascin and fibronectin early in the chordate lineage. Int. J. Biochem. Cell Biol., 2009, 41(2), 424-434. doi: 10.1016/j.biocel.2008.08.003 PMID: 18761101
- Adams, J.C.; Chiquet-Ehrismann, R.; Tucker, R.P. The evolution of tenascins and fibronectin. Cell Adhes. Migr., 2015, 9(1-2), 22-33. doi: 10.4161/19336918.2014.970030 PMID: 25482621
- Orend, G.; Tucker, R.P. Did tenascin-C Co-evolve with the general immune system of vertebrates? Front. Immunol., 2021, 12, 663902. doi: 10.3389/fimmu.2021.663902 PMID: 33912190
- Jones, F.S.; Jones, P.L. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling. Dev. Dyn., 2000, 218(2), 235-259. doi: 10.1002/(SICI)1097-0177(200006)218:23.0.CO;2-G PMID: 10842355
- Xia, S.; Lal, B.; Tung, B.; Wang, S.; Goodwin, C.R.; Laterra, J. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation. Neuro-oncol., 2016, 18(4), 507-517. doi: 10.1093/neuonc/nov171 PMID: 26320116
- Loustau, T.; Abou-Faycal, C.; Erne, W.; zur Wiesch, P.A.; Ksouri, A.; Imhof, T.; Mörgelin, M.; Li, C.; Mathieu, M.; Salomé, N.; Crémel, G.; Dhaouadi, S.; Bouhaouala-Zahar, B.; Koch, M.; Orend, G. Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, "MAREMO". Matrix Biol., 2022, 108, 20-38. doi: 10.1016/j.matbio.2022.02.007 PMID: 35227929
- Midwood, K.S.; Hussenet, T.; Langlois, B.; Orend, G. Advances in tenascin-C biology. Cell. Mol. Life Sci., 2011, 68(19), 3175-3199. doi: 10.1007/s00018-011-0783-6 PMID: 21818551
- Hasegawa, M.; Yoshida, T.; Sudo, A. Tenascin-C in osteoarthritis and rheumatoid arthritis. Front. Immunol., 2020, 11, 577015. doi: 10.3389/fimmu.2020.577015 PMID: 33101302
- Hamidi, H.; Ivaska, J. Every step of the way: Integrins in cancer progression and metastasis. Nat. Rev. Cancer, 2018, 18(9), 533-548. doi: 10.1038/s41568-018-0038-z PMID: 30002479
- Tucker, R.P.; Chiquet-Ehrismann, R. Tenascin-C: Its functions as an integrin ligand. Int. J. Biochem. Cell Biol., 2015, 65, 165-168. doi: 10.1016/j.biocel.2015.06.003 PMID: 26055518
- Yoshida, T.; Akatsuka, T.; Imanaka-Yoshida, K. Tenascin-C and integrins in cancer. Cell Adhes. Migr., 2015, 9(1-2), 96-104. doi: 10.1080/19336918.2015.1008332 PMID: 25793576
- Hendaoui, I.; Tucker, R.P.; Zingg, D.; Bichet, S.; Schittny, J.; Chiquet-Ehrismann, R. Tenascin-C is required for normal Wnt/β-catenin signaling in the whisker follicle stem cell niche. Matrix Biol., 2014, 40, 46-53. doi: 10.1016/j.matbio.2014.08.017 PMID: 25196097
- Chen, S.; Fu, H.; Wu, S.; Zhu, W.; Liao, J.; Hong, X.; Miao, J.; Luo, C.; Wang, Y.; Hou, F.F.; Zhou, L.; Liu, Y. Tenascin-C protects against acute kidney injury by recruiting Wnt ligands. Kidney Int., 2019, 95(1), 62-74. doi: 10.1016/j.kint.2018.08.029 PMID: 30409456
- Gherzi, R.; Carnemolla, B.; Siri, A.; Ponassi, M.; Balza, E.; Zardi, L. Human tenascin gene. Structure of the 5′-region, identification, and characterization of the transcription regulatory sequences. J. Biol. Chem., 1995, 270(7), 3429-3434. doi: 10.1074/jbc.270.7.3429 PMID: 7531707
- Chiovaro, F.; Chiquet-Ehrismann, R.; Chiquet, M. Transcriptional regulation of tenascin genes. Cell Adhes. Migr., 2015, 9(1-2), 34-47. doi: 10.1080/19336918.2015.1008333 PMID: 25793574
- Moritz, S.; Lehmann, S.; Faissner, A.; von Holst, A. An induction gene trap screen in neural stem cells reveals an instructive function of the niche and identifies the splicing regulator sam68 as a tenascin-C-regulated target gene. Stem Cells, 2008, 26(9), 2321-2331. doi: 10.1634/stemcells.2007-1095 PMID: 18617690
- Golledge, J.; Clancy, P.; Maguire, J.; Lincz, L.; Koblar, S. The role of tenascin C in cardiovascular disease. Cardiovasc. Res., 2011, 92(1), 19-28. doi: 10.1093/cvr/cvr183 PMID: 21712412
- González-González, L.; Alonso, J. Periostin: A matricellular protein with multiple functions in cancer development and progression. Front. Oncol., 2018, 8, 225. doi: 10.3389/fonc.2018.00225 PMID: 29946533
- Finch-Edmondson, M.; Sudol, M. Framework to function: Mechanosensitive regulators of gene transcription. Cell. Mol. Biol. Lett., 2016, 21(1), 28. doi: 10.1186/s11658-016-0028-7 PMID: 28536630
- Jinnin, M.; Ihn, H.; Asano, Y.; Yamane, K.; Trojanowska, M.; Tamaki, K. Tenascin-C upregulation by transforming growth factor-β in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene, 2004, 23(9), 1656-1667. doi: 10.1038/sj.onc.1207064 PMID: 15001984
- Jinnin, M.; Ihn, H.; Asano, Y.; Yamane, K.; Trojanowska, M.; Tamaki, K. Platelet derived growth factor induced tenascin-C transcription is phosphoinositide 3-kinase/Akt-dependent and mediated by Ets family transcription factors. J. Cell. Physiol., 2006, 206(3), 718-727. doi: 10.1002/jcp.20527 PMID: 16245312
- Sivasankaran, B.; Degen, M.; Ghaffari, A.; Hegi, M.E.; Hamou, M.F.; Ionescu, M.C.S.; Zweifel, C.; Tolnay, M.; Wasner, M.; Mergenthaler, S.; Miserez, A.R.; Kiss, R.; Lino, M.M.; Merlo, A.; Chiquet-Ehrismann, R.; Boulay, J.L. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. Cancer Res., 2009, 69(2), 458-465. doi: 10.1158/0008-5472.CAN-08-2610 PMID: 19147558
- Oppong, E.; Flink, N.; Cato, A.C.B. Molecular mechanisms of glucocorticoid action in mast cells. Mol. Cell. Endocrinol., 2013, 380(1-2), 119-126. doi: 10.1016/j.mce.2013.05.014 PMID: 23707629
- Ekblom, M.; Fässler, R.; Tomasini-Johansson, B.; Nilsson, K.; Ekblom, P. Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts. J. Cell Biol., 1993, 123(4), 1037-1045. doi: 10.1083/jcb.123.4.1037 PMID: 7693719
- Mackie, E.J.; Scott-Burden, T.; Hahn, A.W.; Kern, F.; Bernhardt, J.; Regenass, S.; Weller, A.; Bühler, F.R. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am. J. Pathol., 1992, 141(2), 377-388. PMID: 1379781
- Flück, M.; Tunç-Civelek, V.; Chiquet, M. Rapid and reciprocal regulation of tenascin-C and tenascin-Y expression by loading of skeletal muscle. J. Cell Sci., 2000, 113(20), 3583-3591. doi: 10.1242/jcs.113.20.3583 PMID: 11017874
- Sarasa-Renedo, A.; Chiquet, M. Mechanical signals regulating extracellular matrix gene expression in fibroblasts. Scand. J. Med. Sci. Sports, 2005, 15(4), 223-230. doi: 10.1111/j.1600-0838.2005.00461.x PMID: 15998339
- Lutz, R.; Sakai, T.; Chiquet, M. Pericellular fibronectin is required for RhoA-dependent responses to cyclic strain in fibroblasts. J. Cell Sci., 2010, 123(9), 1511-1521. doi: 10.1242/jcs.060905 PMID: 20375066
- Asparuhova, M.B.; Gelman, L.; Chiquet, M. Role of the actin cytoskeleton in tuning cellular responses to external mechanical stress. Scand. J. Med. Sci. Sports, 2009, 19(4), 490-499. doi: 10.1111/j.1600-0838.2009.00928.x PMID: 19422655
- Scherer, C.; Pfisterer, L.; Wagner, A.H.; Hödebeck, M.; Cattaruzza, M.; Hecker, M.; Korff, T. Arterial wall stress controls NFAT5 activity in vascular smooth muscle cells. J. Am. Heart Assoc., 2014, 3(2), e000626. doi: 10.1161/JAHA.113.000626 PMID: 24614757
- Chiquet, M. Tenascin: An extracellular matrix protein involved in morphogenesis of epithelial organs. Kidney Int., 1992, 41(3), 629-631. doi: 10.1038/ki.1992.96 PMID: 1374137
- Akbareian, S.E.; Nagy, N.; Steiger, C.E.; Mably, J.D.; Miller, S.A.; Hotta, R.; Molnar, D.; Goldstein, A.M. Enteric neural crest-derived cells promote their migration by modifying their microenvironment through tenascin-C production. Dev. Biol., 2013, 382(2), 446-456. doi: 10.1016/j.ydbio.2013.08.006 PMID: 23958436
- Sahlberg, C.; Aukhil, I.; Thesleff, I. Tenascin-C in developing mouse teeth: Expression of splice variants and stimulation by TGFβ and FGF. Eur. J. Oral Sci., 2001, 109(2), 114-124. doi: 10.1034/j.1600-0722.2001.00990.x PMID: 11347655
- Wiese, S.; Faissner, A. The role of extracellular matrix in spinal cord development. Exp. Neurol., 2015, 274(Pt B), 90-99. doi: 10.1016/j.expneurol.2015.05.018 PMID: 26028310
- Crossin, K.L.; Hoffman, S.; Grumet, M.; Thiery, J.P.; Edelman, G.M. Site-restricted expression of cytotactin during development of the chicken embryo. J. Cell Biol., 1986, 102(5), 1917-1930. doi: 10.1083/jcb.102.5.1917 PMID: 2422181
- Tongiorgi, E. Tenascin-C expression in the trunk of wild-type, cyclops and floating head zebrafish embryos. Brain Res. Bull., 1999, 48(1), 79-88. doi: 10.1016/S0361-9230(98)00149-X PMID: 10210171
- Tan, S.S.; Crossin, K.L.; Hoffman, S.; Edelman, G.M. Asymmetric expression in somites of cytotactin and its proteoglycan ligand is correlated with neural crest cell distribution. Proc. Natl. Acad. Sci., 1987, 84(22), 7977-7981. doi: 10.1073/pnas.84.22.7977 PMID: 2446315
- Fan, C.M.; Tessier-Lavigne, M. Patterning of mammalian somites by surface ectoderm and notochord: Evidence for sclerotome induction by a hedgehog homolog. Cell, 1994, 79(7), 1175-1186. doi: 10.1016/0092-8674(94)90009-4 PMID: 8001153
- Roelink, H.; Augsburger, A.; Heemskerk, J.; Korzh, V.; Norlin, S. Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord. Cell., 1994, 76(4), 761-775. doi: 10.1016/0092-8674(94)90514-2 PMID: 8124714
- Yasuoka, Y. Morphogenetic mechanisms forming the notochord rod: The turgor pressure-sheath strength model. Dev. Growth Differ., 2020, 62(6), 379-390. doi: 10.1111/dgd.12665 PMID: 32275068
- Mackie, E.J.; Thesleff, I.; Chiquet-Ehrismann, R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro . J. Cell Biol., 1987, 105(6), 2569-2579. doi: 10.1083/jcb.105.6.2569 PMID: 2447094
- Tongiorgi, E.; Bernhardt, R.R.; Zinn, K.; Schachner, M. Tenascin-C mRNA is expressed in cranial neural crest cells, in some placodal derivatives, and in discrete domains of the embryonic zebrafish brain. J. Neurobiol., 1995, 28(3), 391-407. doi: 10.1002/neu.480280311 PMID: 8568519
- Hoffman, S.; Crossin, K.L.; Edelman, G.M. Molecular forms, binding functions, and developmental expression patterns of cytotactin and cytotactin-binding proteoglycan, an interactive pair of extracellular matrix molecules. J. Cell Biol., 1988, 106(2), 519-532. doi: 10.1083/jcb.106.2.519 PMID: 2448317
- Faissner, A.; Roll, L.; Theocharidis, U. Tenascin-C in the matrisome of neural stem and progenitor cells. Mol. Cell. Neurosci., 2017, 81, 22-31. doi: 10.1016/j.mcn.2016.11.003 PMID: 27836730
- Song, I.; Dityatev, A. Crosstalk between glia, extracellular matrix and neurons. Brain Res. Bull., 2018, 136, 101-108. doi: 10.1016/j.brainresbull.2017.03.003 PMID: 28284900
- Faissner, A. The tenascin gene family in axon growth and guidance. Cell Tissue Res., 1997, 290(2), 331-341. doi: 10.1007/s004410050938 PMID: 9321695
- Guillon, E.; Bretaud, S.; Ruggiero, F. Slow muscle precursors lay down a collagen XV matrix fingerprint to guide motor axon navigation. J. Neurosci., 2016, 36(9), 2663-2676. doi: 10.1523/JNEUROSCI.2847-15.2016 PMID: 26937007
- Yuasa, S. Bergmann glial development in the mouse cerebellum as revealed by tenascin expression. Anat. Embryol., 1996, 194(3), 223-234. doi: 10.1007/BF00187133 PMID: 8849669
- Reinhard, J.; Joachim, S.C.; Faissner, A. Extracellular matrix remodeling during retinal development. Exp. Eye Res., 2015, 133, 132-140. doi: 10.1016/j.exer.2014.07.001 PMID: 25017186
- Besser, M.; Jagatheaswaran, M.; Reinhard, J.; Schaffelke, P.; Faissner, A. Tenascin C regulates proliferation and differentiation processes during embryonic retinogenesis and modulates the de-differentiation capacity of Müller glia by influencing growth factor responsiveness and the extracellular matrix compartment. Dev. Biol., 2012, 369(2), 163-176. doi: 10.1016/j.ydbio.2012.05.020 PMID: 22691363
- Kardon, G. Muscle and tendon morphogenesis in the avian hind limb. Development, 1998, 125(20), 4019-4032. doi: 10.1242/dev.125.20.4019 PMID: 9735363
- Kannus, P.; Jozsa, L.; Järvinen, T.A.H.; Järvinen, T.L.N.; Kvist, M.; Natri, A.; Järvinen, M. Location and distribution of non-collagenous matrix proteins in musculoskeletal tissues of rat. Histochem. J., 1998, 30(11), 799-810. doi: 10.1023/A:1003448106673 PMID: 9988347
- Mikic, B.; Wong, M.; Chiquet, M.; Hunziker, E.B. Mechanical modulation of tenascin-C and collagen-XII expression during avian synovial joint formation. J. Orthop. Res., 2000, 18(3), 406-415. doi: 10.1002/jor.1100180312 PMID: 10937627
- Imanaka-Yoshida, K.; Matsumoto, K.; Hara, M.; Sakakura, T.; Yoshida, T. The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation, 2003, 71(4-5), 291-298. doi: 10.1046/j.1432-0436.2003.7104506.x PMID: 12823230
- Imanaka-Yoshida, K.; Yoshida, T.; Miyagawa-Tomita, S. Tenascin-C in development and disease of blood vessels. Anat. Rec., 2014, 297(9), 1747-1757. doi: 10.1002/ar.22985 PMID: 25125186
- Ando, K.; Takahashi, M.; Yamagishi, T.; Miyagawa-Tomita, S.; Imanaka-Yoshida, K.; Yoshida, T.; Nakajima, Y. Tenascin C may regulate the recruitment of smooth muscle cells during coronary artery development. Differentiation, 2011, 81(5), 299-306. doi: 10.1016/j.diff.2011.03.002 PMID: 21497984
- Imanaka-Yoshida, K. Extracellular matrix remodeling in vascular development and disease; Etiology and Morphogenesis of Congenital Heart Disease, 2016, pp. 221-226. doi: 10.1007/978-4-431-54628-3_29
- Ishigaki, T.; Imanaka-Yoshida, K.; Shimojo, N.; Matsushima, S.; Taki, W.; Yoshida, T. Tenascin-C enhances crosstalk signaling of integrin αvβ3/PDGFR-β complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells. J. Cell. Physiol., 2011, 226(10), 2617-2624. doi: 10.1002/jcp.22614 PMID: 21792920
- Cohen, E.D.; Ihida-Stansbury, K.; Lu, M.M.; Panettieri, R.A.; Jones, P.L.; Morrisey, E.E. Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway. J. Clin. Invest., 2009, 119(9), 2538-2549. doi: 10.1172/JCI38079 PMID: 19690384
- Mund, S.I.; Schittny, J.C. Tenascin-C deficiency impairs alveolarization and microvascular maturation during postnatal lung development. J. Appl. Physiol., 2020, 128(5), 1287-1298. doi: 10.1152/japplphysiol.00258.2019 PMID: 32078464
- Gremlich, S.; Roth-Kleiner, M.; Equey, L.; Fytianos, K.; Schittny, J.C.; Cremona, T.P. Tenascin-C inactivation impacts lung structure and function beyond lung development. Sci. Rep., 2020, 10(1), 5118. doi: 10.1038/s41598-020-61919-x PMID: 32198404
- Roth-Kleiner, M.; Hirsch, E.; Schittny, J.C. Fetal lungs of tenascin-C-deficient mice grow well, but branch poorly in organ culture. Am. J. Respir. Cell Mol. Biol., 2004, 30(3), 360-366. doi: 10.1165/rcmb.2002-0266OC PMID: 12904321
- Yoshida, T.; Yoshimura, E.; Numata, H.; Sakakura, Y.; Sakakura, T. Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells. Virchows Arch., 1999, 435(5), 496-500. doi: 10.1007/s004280050433 PMID: 10592053
- Tsunoda, T.; Inada, H.; Kalembeyi, I.; Imanaka-Yoshida, K.; Sakakibara, M.; Okada, R.; Katsuta, K.; Sakakura, T.; Majima, Y.; Yoshida, T. Involvement of large tenascin-C splice variants in breast cancer progression. Am. J. Pathol., 2003, 162(6), 1857-1867. doi: 10.1016/S0002-9440(10)64320-9 PMID: 12759243
- Sun, Z.; Schwenzer, A.; Rupp, T.; Murdamoothoo, D.; Vegliante, R.; Lefebvre, O.; Klein, A.; Hussenet, T.; Orend, G. Tenascin-C promotes tumor cell migration and metastasis through integrin α9β1mediated YAP inhibition. Cancer Res., 2018, 78(4), 950-961. doi: 10.1158/0008-5472.CAN-17-1597 PMID: 29259017
- Kohannezhad, K.; Norouzi, S.; Tafazoli, M.; Soleymani, S.; Shahri, N.M.; Tavassoli, A. The in vitro analysis of migration and polarity of blastema cells in the extracellular matrix derived from bovine mesenteric in the presence of fibronectin. Anat. Cell Biol., 2022, 55(2), 229-238. doi: 10.5115/acb.21.233 PMID: 35668476
- Saito, Y.; Imazeki, H.; Miura, S.; Yoshimura, T.; Okutsu, H.; Harada, Y.; Ohwaki, T.; Nagao, O.; Kamiya, S.; Hayashi, R.; Kodama, H.; Handa, H.; Yoshida, T.; Fukai, F. A peptide derived from tenascin-C induces β1 integrin activation through syndecan-4. J. Biol. Chem., 2007, 282(48), 34929-34937. doi: 10.1074/jbc.M705608200 PMID: 17901052
- Thodeti, C.K.; Albrechtsen, R.; Grauslund, M.; Asmar, M.; Larsson, C.; Takada, Y.; Mercurio, A.M.; Couchman, J.R.; Wewer, U.M. ADAM12/syndecan-4 signaling promotes β 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. J. Biol. Chem., 2003, 278(11), 9576-9584. doi: 10.1074/jbc.M208937200 PMID: 12509413
- Midwood, K.S.; Schwarzbauer, J.E. Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways. Mol. Biol. Cell, 2002, 13(10), 3601-3613. doi: 10.1091/mbc.e02-05-0292 PMID: 12388760
- Trebaul, A.; Chan, E.K.; Midwood, K.S. Regulation of fibroblast migration by tenascin-C. Biochem. Soc. Trans., 2007, 35(4), 695-697. doi: 10.1042/BST0350695 PMID: 17635125
- Matsuda, A.; Yoshiki, A.; Tagawa, Y.; Matsuda, H.; Kusakabe, M. Corneal wound healing in tenascin knockout mouse. Invest. Ophthalmol. Vis. Sci., 1999, 40(6), 1071-1080. PMID: 10235540
- El-Karef, A; Yoshida, T; Gabazza, E; Nishioka, T; Inada, H; Sakakura, T Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J. Pathol., 2007, 211(1), 86-94. doi: 10.1002/path.2099
- Mane, D.R.; Rahman, S.U.; Desai, K.M.; Kale, A.D.; Bhat, K.G.; Arany, P.R. Roles of the matricellular protein Tenascin-C in T-lymphocyte trafficking and etiopathogenesis of Oral Lichen Planus. Arch. Oral Biol., 2020, 110, 104622. doi: 10.1016/j.archoralbio.2019.104622 PMID: 31783297
- Clark, R.A.; Erickson, H.P.; Springer, T.A. Tenascin supports lymphocyte rolling. J. Cell Biol., 1997, 137(3), 755-765. doi: 10.1083/jcb.137.3.755 PMID: 9151679
- Wang, Z.; Wei, Q.; Han, L.; Cao, K.; Lan, T.; Xu, Z.; Wang, Y.; Gao, Y.; Xue, J.; Shan, F.; Feng, J.; Xie, X. Tenascin-c renders a proangiogenic phenotype in macrophage via annexin II. J. Cell. Mol. Med., 2018, 22(1), 429-438. doi: 10.1111/jcmm.13332 PMID: 28857429
- Davies, M.G.; Hagen, P-O. Pathobiology of intimal hyperplasia. Br. J. Surg., 2005, 81(9), 1254-1269. doi: 10.1002/bjs.1800810904 PMID: 7953384
- Malabanan, K.P.; Sheahan, A.V.; Khachigian, L.M. Platelet-derived growth factor-BB mediates cell migration through induction of activating transcription factor 4 and tenascin-C. Am. J. Pathol., 2012, 180(6), 2590-2597. doi: 10.1016/j.ajpath.2012.02.009 PMID: 22507839
- Ljubimov, A.V.; Burgeson, R.E.; Butkowski, R.J.; Couchman, J.R.; Zardi, L.; Ninomiya, Y.; Sado, Y.; Huang, Z.S.; Nesburn, A.B.; Kenney, M.C. Basement membrane abnormalities in human eyes with diabetic retinopathy. J. Histochem. Cytochem., 1996, 44(12), 1469-1479. doi: 10.1177/44.12.8985139 PMID: 8985139
- Spirin, K.S.; Saghizadeh, M.; Lewin, S.L.; Zardi, L.; Kenney, M.C.; Ljubimov, A.V. Basement membrane and growth factor gene expression in normal and diabetic human retinas. Curr. Eye Res., 1999, 18(6), 490-499. doi: 10.1076/ceyr.18.6.490.5267 PMID: 10435836
- Castellon, R.; Caballero, S.; Hamdi, H.K.; Atilano, S.R.; Aoki, A.M.; Tarnuzzer, R.W.; Kenney, M.C.; Grant, M.B.; Ljubimov, A.V. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture. Invest. Ophthalmol. Vis. Sci., 2002, 43(8), 2758-2766. PMID: 12147613
- Joester, A.; Faissner, A. The structure and function of tenascins in the nervous system. Matrix Biol., 2001, 20(1), 13-22. doi: 10.1016/S0945-053X(00)00136-0 PMID: 11246000
- Fujioka, T.; Kaneko, N.; Ajioka, I.; Nakaguchi, K.; Omata, T.; Ohba, H.; Fässler, R.; García-Verdugo, J.M.; Sekiguchi, K.; Matsukawa, N.; Sawamoto, K. β1 integrin signaling promotes neuronal migration along vascular scaffolds in the post-stroke brain. EBioMedicine, 2017, 16, 195-203. doi: 10.1016/j.ebiom.2017.01.005 PMID: 28153772
- Kiernan, B.W.; Götz, B.; Faissner, A.; ffrench-Constant, C. Tenascin-C inhibits oligodendrocyte precursor cell migration by both adhesion-dependent and adhesion-independent mechanisms. Mol. Cell. Neurosci., 1996, 7(4), 322-335. doi: 10.1006/mcne.1996.0024 PMID: 8793866
- Wiese, S.; Karus, M.; Faissner, A. Astrocytes as a source for extracellular matrix molecules and cytokines. Front. Pharmacol., 2012, 3, 120. doi: 10.3389/fphar.2012.00120 PMID: 22740833
- Carnemolla, B.; Castellani, P.; Ponassi, M.; Borsi, L.; Urbini, S.; Nicolo, G.; Dorcaratto, A.; Viale, G.; Winter, G.; Neri, D.; Zardi, L. Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody. Am. J. Pathol., 1999, 154(5), 1345-1352. doi: 10.1016/S0002-9440(10)65388-6 PMID: 10329587
- Joester, A.; Faissner, A. Evidence for combinatorial variability of tenascin-C isoforms and developmental regulation in the mouse central nervous system. J. Biol. Chem., 1999, 274(24), 17144-17151. doi: 10.1074/jbc.274.24.17144 PMID: 10358070
- Tucker, R.P. Abnormal neural crest cell migration after the in vivo knockdown of tenascin-C expression with morpholino antisense oligonucleotides. Dev. Dyn., 2001, 222(1), 115-119. doi: 10.1002/dvdy.1171 PMID: 11507773
- Halfter, W.; Chiquet-Ehrismann, R.; Tucker, R.P. The effect of tenascin and embryonic basal lamina on the behavior and morphology of neural crest cells in vitro . Dev. Biol., 1989, 132(1), 14-25. doi: 10.1016/0012-1606(89)90200-5 PMID: 2465193
- Radwanska, A.; Grall, D.; Schaub, S.; Divonne, S.B.F.; Ciais, D.; Rekima, S.; Rupp, T.; Sudaka, A.; Orend, G.; Van Obberghen-Schilling, E. Counterbalancing anti-adhesive effects of Tenascin-C through fibronectin expression in endothelial cells. Sci. Rep., 2017, 7(1), 12762. doi: 10.1038/s41598-017-13008-9 PMID: 28986537
- Yalcin, F.; Dzaye, O.; Xia, S. Tenascin-C Function in Glioma: Immunomodulation and Beyond. Tumor Microenvironment; Springer, 2020, pp. 149-172.
- Nakahara, H.; Gabazza, E.C.; Fujimoto, H.; Nishii, Y.; DAlessandro-Gabazza, C.N.; Bruno, N.E.; Takagi, T.; Hayashi, T.; Maruyama, J.; Maruyama, K.; Imanaka-Yoshida, K.; Suzuki, K.; Yoshida, T.; Adachi, Y.; Taguchi, O. Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse. Eur. J. Immunol., 2006, 36(12), 3334-3345. doi: 10.1002/eji.200636271 PMID: 17125141
- Jayaraj, R.L.; Azimullah, S.; Beiram, R.; Jalal, F.Y.; Rosenberg, G.A. Neuroinflammation: Friend and foe for ischemic stroke. J. Neuroinflammation, 2019, 16(1), 142. doi: 10.1186/s12974-019-1516-2 PMID: 31291966
- Haage, V.; Elmadany, N.; Roll, L.; Faissner, A.; Gutmann, D.H.; Semtner, M.; Kettenmann, H. Tenascin C regulates multiple microglial functions involving TLR4 signaling and HDAC1. Brain Behav. Immun., 2019, 81, 470-483. doi: 10.1016/j.bbi.2019.06.047 PMID: 31271872
- Caso, J.R.; Pradillo, J.M.; Hurtado, O.; Lorenzo, P.; Moro, M.A.; Lizasoain, I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation, 2007, 115(12), 1599-1608. doi: 10.1161/CIRCULATIONAHA.106.603431 PMID: 17372179
- Neumann, J.; Riek-Burchardt, M.; Herz, J.; Doeppner, T.R.; König, R.; Hütten, H.; Etemire, E.; Männ, L.; Klingberg, A.; Fischer, T.; Görtler, M.W.; Heinze, H.J.; Reichardt, P.; Schraven, B.; Hermann, D.M.; Reymann, K.G.; Gunzer, M. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke. Acta Neuropathol., 2015, 129(2), 259-277. doi: 10.1007/s00401-014-1355-2 PMID: 25391494
- Manrique-Castano, D.; Dzyubenko, E.; Borbor, M.; Vasileiadou, P.; Kleinschnitz, C.; Roll, L.; Faissner, A.; Hermann, D.M. Tenascin-C preserves microglia surveillance and restricts leukocyte and, more specifically, T cell infiltration of the ischemic brain. Brain Behav. Immun., 2021, 91, 639-648. doi: 10.1016/j.bbi.2020.10.016 PMID: 33122023
- Kon, S.; Uede, T. The role of α9β1 integrin and its ligands in the development of autoimmune diseases. J. Cell Commun. Signal., 2018, 12(1), 333-342. doi: 10.1007/s12079-017-0413-7 PMID: 28975544
- Song, J.; Schwenzer, A.; Wong, A.; Turcinov, S.; Rims, C.; Martinez, L.R.; Arribas-Layton, D.; Gerstner, C.; Muir, V.S.; Midwood, K.S.; Malmström, V.; James, E.A.; Buckner, J.H. Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis. JCI Insight, 2021, 6(5), e145217. doi: 10.1172/jci.insight.145217 PMID: 33507879
- Momčilović, M.; Stamenković, V.; Jovanović, M.; Andjus, P.R.; Jakovčevski, I.; Schachner, M.; Miljković, Đ. Tenascin-C deficiency protects mice from experimental autoimmune encephalomyelitis. J. Neuroimmunol., 2017, 302, 1-6. doi: 10.1016/j.jneuroim.2016.12.001 PMID: 27974153
- Machino-Ohtsuka, T.; Tajiri, K.; Kimura, T.; Sakai, S.; Sato, A.; Yoshida, T.; Hiroe, M.; Yasutomi, Y.; Aonuma, K.; Imanaka-Yoshida, K. Tenascin-C aggravates autoimmune myocarditis via dendritic cell activation and Th17 cell differentiation. J. Am. Heart Assoc., 2014, 3(6), e001052. doi: 10.1161/JAHA.114.001052 PMID: 25376187
- Bauch, J.; Faissner, A. The extracellular matrix proteins tenascin-c and tenascin-r retard oligodendrocyte precursor maturation and myelin regeneration in a cuprizone-induced long-term demyelination animal model. Cells, 2022, 11(11), 1773. doi: 10.3390/cells11111773 PMID: 35681468
- Franklin, R.J.M.; ffrench-Constant, C. Regenerating CNS myelin from mechanisms to experimental medicines. Nat. Rev. Neurosci., 2017, 18(12), 753-769. doi: 10.1038/nrn.2017.136 PMID: 29142295
- Czopka, T.; Von Holst, A.; Schmidt, G.; Ffrench-Constant, C.; Faissner, A. Tenascin C and tenascin R similarly prevent the formation of myelin membranes in a RhoA-dependent manner, but antagonistically regulate the expression of myelin basic protein via a separate pathway. Glia, 2009, 57(16), 1790-1801. doi: 10.1002/glia.20891 PMID: 19459213
- Wenk, M.B.; Midwood, K.S.; Schwarzbauer, J.E. Tenascin-C suppresses Rho activation. J. Cell Biol., 2000, 150(4), 913-920. doi: 10.1083/jcb.150.4.913 PMID: 10953015
- Galon, J.; Costes, A.; Sanchez-Cabo, F.; Kirilovsky, A.; Mlecnik, B.; Lagorce-Pagès, C.; Tosolini, M.; Camus, M.; Berger, A.; Wind, P.; Zinzindohoué, F.; Bruneval, P.; Cugnenc, P.H.; Trajanoski, Z.; Fridman, W.H.; Pagès, F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science, 2006, 313(5795), 1960-1964. doi: 10.1126/science.1129139 PMID: 17008531
- Huang, J.Y.; Cheng, Y.J.; Lin, Y.P.; Lin, H.C.; Su, C.C.; Juliano, R.; Yang, B.C. Extracellular matrix of glioblastoma inhibits polarization and transmigration of T cells: the role of tenascin-C in immune suppression. J. Immunol., 2010, 185(3), 1450-1459. doi: 10.4049/jimmunol.0901352 PMID: 20622113
- Jachetti, E.; Caputo, S.; Mazzoleni, S.; Brambillasca, C.S.; Parigi, S.M.; Grioni, M.; Piras, I.S.; Restuccia, U.; Calcinotto, A.; Freschi, M.; Bachi, A.; Galli, R.; Bellone, M. Tenascin-C protects cancer stemlike cells from immune surveillance by arresting T-cell activation. Cancer Res., 2015, 75(10), 2095-2108. doi: 10.1158/0008-5472.CAN-14-2346 PMID: 25808872
- Su, C.C.; Lin, Y.P.; Cheng, Y.J.; Huang, J.Y.; Chuang, W.J.; Shan, Y.S.; Yang, B.C. Phosphatidylinositol 3-kinase/Akt activation by integrin-tumor matrix interaction suppresses Fas-mediated apoptosis in T cells. J. Immunol., 2007, 179(7), 4589-4597. doi: 10.4049/jimmunol.179.7.4589 PMID: 17878356
- Loike, J.D.; Cao, L.; Budhu, S.; Hoffman, S.; Silverstein, S.C. Blockade of α 5 β 1 integrins reverses the inhibitory effect of tenascin on chemotaxis of human monocytes and polymorphonuclear leukocytes through three-dimensional gels of extracellular matrix proteins. J. Immunol., 2001, 166(12), 7534-7542. doi: 10.4049/jimmunol.166.12.7534 PMID: 11390508
- Hauzenberger, D.; Olivier, P.; Gundersen, D.; Rüegg, C. Tenascin-C inhibits β1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1 5 repeats to fibronectin. Eur. J. Immunol., 1999, 29(5), 1435-1447. doi: 10.1002/(SICI)1521-4141(199905)29:053.0.CO;2-N PMID: 10359097
- Rougerie, P.; Delon, J. Rho GTPases: Masters of T lymphocyte migration and activation. Immunol. Lett., 2012, 142(1-2), 1-13. doi: 10.1016/j.imlet.2011.12.003 PMID: 22207038
- Tybulewicz, V.L.J.; Henderson, R.B. Rho family GTPases and their regulators in lymphocytes. Nat. Rev. Immunol., 2009, 9(9), 630-644. doi: 10.1038/nri2606 PMID: 19696767
- Mackie, E.J.; Tucker, R.P. The tenascin-C knockout revisited. J. Cell Sci., 1999, 112(22), 3847-3853. doi: 10.1242/jcs.112.22.3847 PMID: 10547346
- Mangan, R.J.; Stamper, L.; Ohashi, T.; Eudailey, J.A.; Go, E.P.; Jaeger, F.H.; Itell, H.L.; Watts, B.E.; Fouda, G.G.; Erickson, H.P.; Alam, S.M.; Desaire, H.; Permar, S.R. Determinants of Tenascin-C and HIV-1 envelope binding and neutralization. Mucosal Immunol., 2019, 12(4), 1004-1012. doi: 10.1038/s41385-019-0164-2 PMID: 30976088
- Sur, S.; Khatun, M.; Steele, R.; Isbell, T.S.; Ray, R.; Ray, R.B. Exosomes from COVID-19 patients carry Tenascin-C and Fibrinogen-β in triggering inflammatory signals in cells of distant organ. Int. J. Mol. Sci., 2021, 22(6), 3184. doi: 10.3390/ijms22063184 PMID: 33804769
- Amemiya, K.; Kobayashi, T.; Kataoka, Y.; Iwai, T.; Nakagawa, S.; Morita, Y.; Ohta-Ogo, K.; Matsumoto, M.; Ikeda, Y.; Katano, H.; Suzuki, T.; Izumi, C.; Noguchi, T.; Hatakeyama, K. Myocarditis after COVID-19 mRNA vaccination in three young adult males: Significance of biopsy in vaccine-associated myocarditis. Pathol. Int., 2022, 72(7), 385-387. doi: 10.1111/pin.13234 PMID: 35583173
- Tajiri, K.; Yonebayashi, S.; Li, S.; Ieda, M. Immunomodulatory role of tenascin-C in myocarditis and inflammatory cardiomyopathy. Front. Immunol., 2021, 12, 624703. doi: 10.3389/fimmu.2021.624703 PMID: 33692798
- Zeng, H.L.; Chen, D.; Yan, J.; Yang, Q.; Han, Q.Q.; Li, S.S.; Cheng, L. Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients. FEBS J., 2021, 288(17), 5190-5200. doi: 10.1111/febs.15609 PMID: 33098359
- Zuliani-Alvarez, L.; Piccinini, A.M. A virological view of tenascin-C in infection. Am. J. Physiol. Cell Physiol., 2023, 324(1), C1-C9. doi: 10.1152/ajpcell.00333.2022 PMID: 36458980
- Yuan, W.; Zhang, W.; Yang, X.; Zhou, L.; Hanghua, Z.; Xu, K. Clinical significance and prognosis of serum tenascin-C in patients with sepsis. BMC Anesthesiol., 2018, 18(1), 170. doi: 10.1186/s12871-018-0634-1 PMID: 30442110
- Albacete-Albacete, L.; Navarro-Lérida, I.; López, J.A.; Martín-Padura, I.; Astudillo, A.M.; Ferrarini, A.; Van-Der-Heyden, M.; Balsinde, J.; Orend, G.; Vázquez, J.; del Pozo, M.Á. ECM deposition is driven by caveolin-1dependent regulation of exosomal biogenesis and cargo sorting. J. Cell Biol., 2020, 219(11), e202006178. doi: 10.1083/jcb.202006178 PMID: 33053168
- Campos, A.; Salomon, C.; Bustos, R.; Díaz, J.; Martínez, S.; Silva, V.; Reyes, C.; Díaz-Valdivia, N.; Varas-Godoy, M.; Lobos-González, L.; Quest, A.F.G. Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines. Nanomedicine, 2018, 13(20), 2597-2609. doi: 10.2217/nnm-2018-0094 PMID: 30338706
- Ji, H.; Greening, D.W.; Barnes, T.W.; Lim, J.W.; Tauro, B.J.; Rai, A.; Xu, R.; Adda, C.; Mathivanan, S.; Zhao, W.; Xue, Y.; Xu, T.; Zhu, H.J.; Simpson, R.J. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics, 2013, 13(10-11), 1672-1686. doi: 10.1002/pmic.201200562 PMID: 23585443
- Zheng, J.; Hernandez, J.M.; Doussot, A.; Bojmar, L.; Zambirinis, C.P.; Costa-Silva, B.; van Beek, E.J.A.H.; Mark, M.T.; Molina, H.; Askan, G.; Basturk, O.; Gonen, M.; Kingham, T.P.; Allen, P.J.; DAngelica, M.I.; DeMatteo, R.P.; Lyden, D.; Jarnagin, W.R. Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer. HPB, 2018, 20(7), 597-604. doi: 10.1016/j.hpb.2017.12.010 PMID: 29339034
- Mirzaei, R.; Sarkar, S.; Dzikowski, L.; Rawji, K.S.; Khan, L.; Faissner, A. Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity; Taylor & Francis, 2018. doi: 10.1080/2162402X.2018.1478647
- Pedretti, M.; Soltermann, A.; Arni, S.; Weder, W.; Neri, D.; Hillinger, S. Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: Two human antibodies investigated in clinical trials in patients with cancer. Lung Cancer, 2009, 64(1), 28-33. doi: 10.1016/j.lungcan.2008.07.013 PMID: 18799229
- Niebroj-Dobosz, I; Madej-Pilarczyk, A; Marchel, M Circulating tenascin-C levels in patients with dilated cardiomyopathy in the course of Emery-Dreifuss muscular dystrophy. Clin Chim Acta, 2011, 412(17-18), 1533-1538. doi: 10.1016/j.cca.2011.04.033 PMID: 21596026
- Page, T.H.; Charles, P.J.; Piccinini, A.M.; Nicolaidou, V.; Taylor, P.C.; Midwood, K.S. Raised circulating tenascin-C in rheumatoid arthritis. Arthritis Res. Ther., 2012, 14(6), R260. doi: 10.1186/ar4105 PMID: 23193984
- Indumathi, A.; Senthilkumar, G.P.; Jayashree, K.; Ramesh Babu, K. Assessment of circulating fibrotic proteins (periostin and tenascin -C) In Type 2 diabetes mellitus patients with and without retinopathy. Endocrine, 2022, 76(3), 570-577. doi: 10.1007/s12020-022-03027-6 PMID: 35274283
- Tenascins in CNS lesions. Seminars in cell & developmental biology; Roll, L.; Faissner, A., Eds.; Elsevier, 2019.
- Hausmann, R.; Betz, P. Course of glial immunoreactivity for vimentin, tenascin and α1-antichymotrypsin after traumatic injury to human brain. Int. J. Legal Med., 2001, 114(6), 338-342. doi: 10.1007/s004140000199 PMID: 11508799
- Stamenkovic, V.; Stamenkovic, S.; Jaworski, T.; Gawlak, M.; Jovanovic, M.; Jakovcevski, I.; Wilczynski, G.M.; Kaczmarek, L.; Schachner, M.; Radenovic, L.; Andjus, P.R. The extracellular matrix glycoprotein tenascin-C and matrix metalloproteinases modify cerebellar structural plasticity by exposure to an enriched environment. Brain Struct. Funct., 2017, 222(1), 393-415. doi: 10.1007/s00429-016-1224-y PMID: 27089885
- Geissler, M.; Gottschling, C.; Aguado, A.; Rauch, U.; Wetzel, C.H.; Hatt, H.; Faissner, A. Primary hippocampal neurons, which lack four crucial extracellular matrix molecules, display abnormalities of synaptic structure and function and severe deficits in perineuronal net formation. J. Neurosci., 2013, 33(18), 7742-7755. doi: 10.1523/JNEUROSCI.3275-12.2013 PMID: 23637166
- Jansen, S.; Gottschling, C.; Faissner, A.; Manahan-Vaughan, D. Intrinsic cellular and molecular properties of in vivo hippocampal synaptic plasticity are altered in the absence of key synaptic matrix molecules. Hippocampus, 2017, 27(8), 920-933. doi: 10.1002/hipo.22742 PMID: 28512860
- Quattromani, M.J.; Hakon, J.; Rauch, U.; Bauer, A.Q.; Wieloch, T. Changes in resting-state functional connectivity after stroke in a mouse brain lacking extracellular matrix components. Neurobiol. Dis., 2018, 112, 91-105. doi: 10.1016/j.nbd.2018.01.011 PMID: 29367009
- Dzyubenko, E.; Manrique-Castano, D.; Kleinschnitz, C.; Faissner, A.; Hermann, D.M. Topological remodeling of cortical perineuronal nets in focal cerebral ischemia and mild hypoperfusion. Matrix Biol., 2018, 74, 121-132. doi: 10.1016/j.matbio.2018.08.001 PMID: 30092283
- ekeljić, V.; Andjus, P.R. Tenascin-C and its functions in neuronal plasticity. Int. J. Biochem. Cell Biol., 2012, 44(6), 825-829. doi: 10.1016/j.biocel.2012.02.014 PMID: 22405938
- Wlodarczyk, J.; Mukhina, I.; Kaczmarek, L.; Dityatev, A. Extracellular matrix molecules, their receptors, and secreted proteases in synaptic plasticity. Dev. Neurobiol., 2011, 71(11), 1040-1053. doi: 10.1002/dneu.20958 PMID: 21793226
- Xie, K.; Liu, Y.; Hao, W.; Walter, S.; Penke, B.; Hartmann, T.; Schachner, M.; Fassbender, K. Tenascin-C deficiency ameliorates Alzheimers disease-related pathology in mice. Neurobiol. Aging, 2013, 34(10), 2389-2398. doi: 10.1016/j.neurobiolaging.2013.04.013 PMID: 23673309
- Scheffler, B.; Faissner, A.; Beck, H.; Behle, K.; Wolf, H.K.; Wiestler, O.D.; Blümcke, I. Hippocampal loss of tenascin boundaries in Ammons horn sclerosis. Glia, 1997, 19(1), 35-46. doi: 10.1002/(SICI)1098-1136(199701)19:13.0.CO;2-9 PMID: 8989566
- Mi, Z.; Halfter, W.; Abrahamson, E.E.; Klunk, W.E.; Mathis, C.A.; Mufson, E.J.; Ikonomovic, M.D. Tenascin-C is associated with cored amyloid-β plaques in Alzheimer disease and pathology burdened cognitively normal elderly. J. Neuropathol. Exp. Neurol., 2016, 75(9), 868-876. doi: 10.1093/jnen/nlw062 PMID: 27444354
- Hasanzadeh, Z.; Nourazarian, A.; Nikanfar, M.; Laghousi, D.; Vatankhah, A.M.; Sadrirad, S. Evaluation of the serum Dkk-1, tenascin-C, oxidative stress markers levels and Wnt signaling pathway genes expression in patients with Alzheimers disease. J. Mol. Neurosci., 2021, 71(4), 879-887. doi: 10.1007/s12031-020-01710-9 PMID: 32935274
- Soares, H.D.; Potter, W.Z.; Pickering, E.; Kuhn, M.; Immermann, F.W.; Shera, D.M.; Ferm, M.; Dean, R.A.; Simon, A.J.; Swenson, F.; Siuciak, J.A.; Kaplow, J.; Thambisetty, M.; Zagouras, P.; Koroshetz, W.J.; Wan, H.I.; Trojanowski, J.Q.; Shaw, L.M. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch. Neurol., 2012, 69(10), 1310-1317. doi: 10.1001/archneurol.2012.1070 PMID: 22801723
- Morellini, F.; Schachner, M. Enhanced novelty-induced activity, reduced anxiety, delayed resynchronization to daylight reversal and weaker muscle strength in tenascin-C-deficient mice. Eur. J. Neurosci., 2006, 23(5), 1255-1268. doi: 10.1111/j.1460-9568.2006.04657.x PMID: 16553788
- Stamenkovic, V.; Milenkovic, I.; Galjak, N.; Todorovic, V.; Andjus, P. Enriched environment alters the behavioral profile of tenascin-C deficient mice. Behav. Brain Res., 2017, 331, 241-253. doi: 10.1016/j.bbr.2017.05.047 PMID: 28549651
- Hamza, O.; Kiss, A.; Kramer, A.M.; Trojanek, S.; Abraham, D.; Acar, E.; Nagel, F.; Tretter, V.E.; Kitzwögerer, M.; Podesser, B.K. Tenascin C promotes valvular remodeling in two large animal models of ischemic mitral regurgitation. Basic Res. Cardiol., 2020, 115(6), 76. doi: 10.1007/s00395-020-00837-5 PMID: 33258993
- Peng, R.; Li, Y. Associations between tenascin-C and testosterone deficiency in men with major depressive disorder: A cross-sectional retrospective study. J. Inflamm. Res., 2021, 14, 897-905. doi: 10.2147/JIR.S298270 PMID: 33758529
- Peng, R.; Dai, W.; Li, Y. High serum levels of tenascin-C are associated with suicide attempts in depressed patients. Psychiatry Res., 2018, 268, 60-64. doi: 10.1016/j.psychres.2018.06.069 PMID: 30005189
- Zhang, Z.; Yu, B.; Gu, Y.; Zhou, S.; Qian, T.; Wang, Y.; Ding, G.; Ding, F.; Gu, X. Fibroblast-derived tenascin-C promotes Schwann cell migration through β1-integrin dependent pathway during peripheral nerve regeneration. Glia, 2016, 64(3), 374-385. doi: 10.1002/glia.22934 PMID: 26497118
- Kwiatkowska, M.; Reinhard, J.; Roll, L.; Kraft, N.; Dazert, S.; Faissner, A.; Volkenstein, S. The expression pattern and inhibitory influence of Tenascin-C on the growth of spiral ganglion neurons suggest a regulatory role as boundary formation molecule in the postnatal mouse inner ear. Neuroscience, 2016, 319, 46-58. doi: 10.1016/j.neuroscience.2016.01.039 PMID: 26812032
- Dugu, L.; Hayashida, S.; Nakahara, T.; Xie, L.; Iwashita, Y.; Liu, X.; Uchi, H.; Tateuchi, S.; Takahara, M.; Oda, Y.; Moroi, Y.; Furue, M. Aberrant expression of tenascin-c and neuronatin in malignant peripheral nerve sheath tumors. Eur. J. Dermatol., 2010, 20(5), 580-584. PMID: 20610366
- Lu, P.; Takai, K.; Weaver, V.M.; Werb, Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb. Perspect. Biol., 2011, 3(12), a005058. doi: 10.1101/cshperspect.a005058 PMID: 21917992
- Dueck, M.; Riedl, S.; Hinz, U.; Tandara, A.; Möller, P.; Herfarth, C.; Faissner, A. Detection of tenascin-C isoforms in colorectal mucosa, ulcerative colitis, carcinomas and liver metastases. Int. J. Cancer, 1999, 82(4), 477-483. doi: 10.1002/(SICI)1097-0215(19990812)82:43.0.CO;2-5 PMID: 10404058
- Suzuki, H.; Sasada, M.; Kamiya, S.; Ito, Y.; Watanabe, H.; Okada, Y.; Ishibashi, K.; Iyoda, T.; Yanaka, A.; Fukai, F. The promoting effect of the extracellular matrix peptide TNIIIA2 derived from tenascin-C in colon cancer cell infiltration. Int. J. Mol. Sci., 2017, 18(1), 181. doi: 10.3390/ijms18010181 PMID: 28106752
- Silacci, M.; Brack, S.S.; Späth, N.; Buck, A.; Hillinger, S.; Arni, S.; Weder, W.; Zardi, L.; Neri, D. Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo. Protein Eng. Des. Sel., 2006, 19(10), 471-478. doi: 10.1093/protein/gzl033 PMID: 16928692
- Schwager, K.; Villa, A.; Rösli, C.; Neri, D.; Rösli-Khabas, M.; Moser, G. A comparative immunofluorescence analysis of three clinical-stage antibodies in head and neck cancer. Head Neck Oncol., 2011, 3(1), 25. doi: 10.1186/1758-3284-3-25 PMID: 21548989
- Frey, K.; Fiechter, M.; Schwager, K.; Belloni, B.; Barysch, M.J.; Neri, D.; Dummer, R. Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions. Exp. Dermatol., 2011, 20(8), 685-688. doi: 10.1111/j.1600-0625.2011.01314.x PMID: 21649738
- Wilson, K.E.; Langdon, S.P.; Lessells, A.M.; Miller, W.R. Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours. Br. J. Cancer, 1996, 74(7), 999-1004. doi: 10.1038/bjc.1996.480 PMID: 8855965
- Adams, M.; Jones, J.L.; Walker, R.A.; Pringle, J.H.; Bell, S.C. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. Cancer Res., 2002, 62(11), 3289-3297. PMID: 12036947
- Berndt, A.; Anger, K.; Richter, P.; Borsi, L.; Brack, S.; Silacci, M.; Franz, M.; Wunderlich, H.; Gajda, M.; Zardi, L.; Neri, D.; Kosmehl, H. Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder. J. Cancer Res. Clin. Oncol., 2006, 132(8), 537-546. doi: 10.1007/s00432-006-0106-8 PMID: 16788848
- Richter, P.; Tost, M.; Franz, M.; Altendorf-Hofmann, A.; Junker, K.; Borsi, L.; Neri, D.; Kosmehl, H.; Wunderlich, H.; Berndt, A. B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder? J. Cancer Res. Clin. Oncol., 2009, 135(10), 1351-1358. doi: 10.1007/s00432-009-0576-6 PMID: 19326143
- Guttery, D.S.; Hancox, R.A.; Mulligan, K.T.; Hughes, S.; Lambe, S.M.; Pringle, J.H.; Walker, R.A.; Jones, J.L.; Shaw, J.A. Association of invasion-promoting tenascin-C additional domains with breast cancers in young women. Breast Cancer Res., 2010, 12(4), R57. doi: 10.1186/bcr2618 PMID: 20678196
- Iyoda, T.; Fujita, M.; Fukai, F. Biologically active TNIIIA2 region in tenascin-C molecule: A major contributor to elicit aggressive malignant phenotypes from tumors/tumor stroma. Front. Immunol., 2020, 11, 610096. doi: 10.3389/fimmu.2020.610096 PMID: 33362799
- Hancox, R.A.; Allen, M.D.; Holliday, D.L.; Edwards, D.R.; Pennington, C.J.; Guttery, D.S.; Shaw, J.A.; Walker, R.A.; Pringle, J.H.; Jones, J.L. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Res., 2009, 11(2), R24. doi: 10.1186/bcr2251 PMID: 19405959
- Sun, Z.; Velázquez-Quesada, I.; Murdamoothoo, D.; Ahowesso, C.; Yilmaz, A.; Spenlé, C.; Averous, G.; Erne, W.; Oberndorfer, F.; Oszwald, A.; Kain, R.; Bourdon, C.; Mangin, P.; Deligne, C.; Midwood, K.; Abou-Faycal, C.; Lefebvre, O.; Klein, A.; van der Heyden, M.; Chenard, M.P.; Christofori, G.; Mathelin, C.; Loustau, T.; Hussenet, T.; Orend, G. Tenascin-C increases lung metastasis by impacting blood vessel invasions. Matrix Biol., 2019, 83, 26-47. doi: 10.1016/j.matbio.2019.07.001 PMID: 31288084
- Kasprzycka, M.; Hammarström, C.; Haraldsen, G. Tenascins in fibrotic disordersfrom bench to bedside. Cell Adhes. Migr., 2015, 9(1-2), 83-89. doi: 10.4161/19336918.2014.994901 PMID: 25793575
- Katoh, D.; Kozuka, Y.; Noro, A.; Ogawa, T.; Imanaka-Yoshida, K.; Yoshida, T. Tenascin-C induces phenotypic changes in fibroblasts to myofibroblasts with high contractility through the integrin αvβ1/transforming growth factor β/SMAD signaling axis in human breast cancer. Am. J. Pathol., 2020, 190(10), 2123-2135. doi: 10.1016/j.ajpath.2020.06.008 PMID: 32650003
- Yeo, S.Y.; Lee, K.W.; Shin, D.; An, S.; Cho, K.H.; Kim, S.H. A positive feedback loop bi-stably activates fibroblasts. Nat. Commun., 2018, 9(1), 3016. doi: 10.1038/s41467-018-05274-6 PMID: 30069061
- Huang, W.; Chiquet-Ehrismann, R.; Moyano, J.V.; Garcia-Pardo, A.; Orend, G. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res., 2001, 61(23), 8586-8594. PMID: 11731446
- Fujita, M.; Sasada, M.; Iyoda, T.; Fukai, F. Involvement of integrin-activating peptides derived from tenascin-c in cancer aggression and new anticancer strategy using the fibronectin-derived integrin-inactivating peptide. Molecules, 2020, 25(14), 3239. doi: 10.3390/molecules25143239 PMID: 32708610
- Fujita, M.; Sasada, M.; Iyoda, T.; Osada, S.; Kodama, H.; Fukai, F. Biofunctional peptide FNIII14. Encyclopedia, 2021, 1(2), 350-359. doi: 10.3390/encyclopedia1020029
- Fujita, M.; Sasada, M.; Iyoda, T.; Nagai, R.; Kudo, C.; Yamamoto, T.; Osada, S.; Kodama, H.; Fukai, F. Anoikis resistance conferred by tenascin-C-derived peptide TNIIIA2 and its disruption by integrin inactivation. Biochem. Biophys. Res. Commun., 2021, 536, 14-19. doi: 10.1016/j.bbrc.2020.12.050 PMID: 33360093
- Swindle, C.S.; Tran, K.T.; Johnson, T.D.; Banerjee, P.; Mayes, A.M.; Griffith, L.; Wells, A. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J. Cell Biol., 2001, 154(2), 459-468. doi: 10.1083/jcb.200103103 PMID: 11470832
- Iyer, A.K.V.; Tran, K.T.; Borysenko, C.W.; Cascio, M.; Camacho, C.J.; Blair, H.C.; Bahar, I.; Wells, A. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. J. Cell. Physiol., 2007, 211(3), 748-758. doi: 10.1002/jcp.20986 PMID: 17311283
- Brösicke, N.; Faissner, A. Role of tenascins in the ECM of gliomas. Cell Adhes. Migr., 2015, 9(1-2), 131-140. doi: 10.1080/19336918.2014.1000071 PMID: 25695402
- Cai, J.; Lu, W.; Du, S.; Guo, Z.; Wang, H.; Wei, W.; Shen, X. Tenascin-C modulates cell cycle progression to enhance tumour cell proliferation through AKT/FOXO1 signalling in pancreatic cancer. J. Cancer, 2018, 9(23), 4449-4462. doi: 10.7150/jca.25926 PMID: 30519351
- Langlois, B.; Saupe, F.; Rupp, T.; Arnold, C.; van der Heyden, M.; Orend, G.; Hussenet, T. AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients. Oncotarget, 2014, 5(21), 10529-10545. doi: 10.18632/oncotarget.2470 PMID: 25301723
- Kubo, Y.; Ishikawa, K.; Mori, K.; Kobayashi, Y.; Nakama, T.; Arima, M.; Nakao, S.; Hisatomi, T.; Haruta, M.; Sonoda, K.H.; Yoshida, S. Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy. Sci. Rep., 2020, 10(1), 9299. doi: 10.1038/s41598-020-66278-1 PMID: 32518264
- Tanaka, K.; Hiraiwa, N.; Hashimoto, H.; Yamazaki, Y.; Kusakabe, M. Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Int. J. Cancer, 2004, 108(1), 31-40. doi: 10.1002/ijc.11509 PMID: 14618612
- Rupp, T.; Langlois, B.; Koczorowska, M.M.; Radwanska, A.; Sun, Z.; Hussenet, T.; Lefebvre, O.; Murdamoothoo, D.; Arnold, C.; Klein, A.; Biniossek, M.L.; Hyenne, V.; Naudin, E.; Velazquez-Quesada, I.; Schilling, O.; Van Obberghen-Schilling, E.; Orend, G. Tenascin-C orchestrates glioblastoma angiogenesis by modulation of pro-and anti-angiogenic signaling. Cell Rep., 2016, 17(10), 2607-2619. doi: 10.1016/j.celrep.2016.11.012 PMID: 27926865
- Fischer, D.; Brown-Lüdi, M.; Schulthess, T.; Chiquet-Ehrismann, R. Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth. J. Cell Sci., 1997, 110(13), 1513-1522. doi: 10.1242/jcs.110.13.1513 PMID: 9224768
- Wawrzyniak, D.; Grabowska, M.; Głodowicz, P.; Kuczyński, K.; Kuczyńska, B.; Fedoruk-Wyszomirska, A.; Rolle, K. Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment. PLoS One, 2020, 15(8), e0237889. doi: 10.1371/journal.pone.0237889 PMID: 32817625
- San Martin, R.; Pathak, R.; Jain, A.; Jung, S.Y.; Hilsenbeck, S.G.; Piña-Barba, M.C.; Sikora, A.G.; Pienta, K.J.; Rowley, D.R. Tenascin-C and integrin α9 mediate interactions of prostate cancer with the bone microenvironment. Cancer Res., 2017, 77(21), 5977-5988. doi: 10.1158/0008-5472.CAN-17-0064 PMID: 28916657
- Rappl, A.; Piontek, G.; Schlegel, J. EGFR-dependent migration of glial cells is mediated by reorganisation of N-cadherin. J. Cell Sci., 2008, 121(24), 4089-4097. doi: 10.1242/jcs.027995 PMID: 19033391
- Steitz, A.M.; Steffes, A.; Finkernagel, F.; Unger, A.; Sommerfeld, L.; Jansen, J.M.; Wagner, U.; Graumann, J.; Müller, R.; Reinartz, S. Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C. Cell Death Dis., 2020, 11(4), 249. doi: 10.1038/s41419-020-2438-8 PMID: 32312959
- Lange, K.; Kammerer, M.; Saupe, F.; Hegi, M.E.; Grotegut, S.; Fluri, E.; Orend, G. Combined lysophosphatidic acid/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment. Cancer Res., 2008, 68(17), 6942-6952. doi: 10.1158/0008-5472.CAN-08-0347 PMID: 18757408
- Sarkar, S.; Nuttall, R.K.; Liu, S.; Edwards, D.R.; Yong, V.W. Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res., 2006, 66(24), 11771-11780. doi: 10.1158/0008-5472.CAN-05-0470 PMID: 17178873
- Sarkar, S.; Zemp, F.J.; Senger, D.; Robbins, S.M.; Yong, V.W. ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumorinitiating cells. Neuro-oncol., 2015, 17(8), 1095-1105. doi: 10.1093/neuonc/nou362 PMID: 25646025
- Hauzenberger, D.; Bergström, S.E.; Klominek, J.; Sundqvist, K.G. Spectrum of extracellular matrix degrading enzymes in normal and malignant T lymphocytes. Anticancer Res., 1999, 19(3A), 1945-1952. PMID: 10470139
- Benbow, J.H.; Thompson, K.J.; Cope, H.L.; Brandon-Warner, E.; Culberson, C.R.; Bossi, K.L.; Li, T.; Russo, M.W.; Gersin, K.S.; McKillop, I.H.; deLemos, A.S.; Schrum, L.W. Diet-induced obesity enhances progression of hepatocellular carcinoma through tenascin-C/toll-like receptor 4 signaling. Am. J. Pathol., 2016, 186(1), 145-158. doi: 10.1016/j.ajpath.2015.09.015 PMID: 26603137
- Hanmin, C.; Xiangyue, Z.; Lenahan, C.; Ling, W.; Yibo, O.; Yue, H. Pleiotropic role of tenascin-C in central nervous system diseases: From basic to clinical applications. Front. Neurol., 2020, 11, 576230. doi: 10.3389/fneur.2020.576230 PMID: 33281711
- Murdamoothoo, D.; Sun, Z.; Yilmaz, A.; Riegel, G.; Abou-Faycal, C.; Deligne, C.; Velazquez-Quesada, I.; Erne, W.; Nascimento, M.; Mörgelin, M.; Cremel, G.; Paul, N.; Carapito, R.; Veber, R.; Dumortier, H.; Yuan, J.; Midwood, K.S.; Loustau, T.; Orend, G. Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression. EMBO Mol. Med., 2021, 13(6), e13270. doi: 10.15252/emmm.202013270 PMID: 33988305
- Deligne, C.; Murdamoothoo, D.; Gammage, A.N.; Gschwandtner, M.; Erne, W.; Loustau, T.; Marzeda, A.M.; Carapito, R.; Paul, N.; Velazquez-Quesada, I.; Mazzier, I.; Sun, Z.; Orend, G.; Midwood, K.S. Matrix-targeting immunotherapy controls tumor growth and spread by switching macrophage phenotype. Cancer Immunol. Res., 2020, 8(3), 368-382. doi: 10.1158/2326-6066.CIR-19-0276 PMID: 31941671
- Spenlé, C.; Loustau, T.; Murdamoothoo, D.; Erne, W.; Beghelli-de la Forest Divonne, S.; Veber, R.; Petti, L.; Bourdely, P.; Mörgelin, M.; Brauchle, E.M.; Cremel, G.; Randrianarisoa, V.; Camara, A.; Rekima, S.; Schaub, S.; Nouhen, K.; Imhof, T.; Hansen, U.; Paul, N.; Carapito, R.; Pythoud, N.; Hirschler, A.; Carapito, C.; Dumortier, H.; Mueller, C.G.; Koch, M.; Schenke-Layland, K.; Kon, S.; Sudaka, A.; Anjuère, F.; Van Obberghen-Schilling, E.; Orend, G. Tenascin-C orchestrates an immune suppressive tumor microenvironment in oral squamous cell carcinoma. Cancer Immunol. Res., 2020, 8(9), 1122-1138. doi: 10.1158/2326-6066.CIR-20-0074 PMID: 32665262
- Wang, Y.; Xu, H.; Zhu, B.; Qiu, Z.; Lin, Z. Systematic identification of the key candidate genes in breast cancer stroma. Cell. Mol. Biol. Lett., 2018, 23(1), 44. doi: 10.1186/s11658-018-0110-4 PMID: 30237810
- Hongu, T.; Pein, M.; Insua-Rodríguez, J.; Gutjahr, E.; Mattavelli, G.; Meier, J.; Decker, K.; Descot, A.; Bozza, M.; Harbottle, R.; Trumpp, A.; Sinn, H.P.; Riedel, A.; Oskarsson, T. Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs. Nat. Can., 2022, 3(4), 486-504. doi: 10.1038/s43018-022-00353-6 PMID: 35469015
- Islam, M.S.; Kusakabe, M.; Horiguchi, K.; Iino, S.; Nakamura, T.; Iwanaga, K.; Hashimoto, H.; Matsumoto, S.; Murata, T.; Hori, M.; Ozaki, H. PDGF and TGF-β promote tenascin-C expression in subepithelial myofibroblasts and contribute to intestinal mucosal protection in mice. Br. J. Pharmacol., 2014, 171(2), 375-388. doi: 10.1111/bph.12452 PMID: 24116743
- Lu, Y.; Su, F.; Li, Q.; Zhang, J.; Li, Y.; Tang, T.; Hu, Q.; Yu, X.Q. Pattern recognition receptors in Drosophila immune responses. Dev. Comp. Immunol., 2020, 102, 103468. doi: 10.1016/j.dci.2019.103468 PMID: 31430488
- Kanayama, M.; Kurotaki, D.; Morimoto, J.; Asano, T.; Matsui, Y.; Nakayama, Y.; Saito, Y.; Ito, K.; Kimura, C.; Iwasaki, N.; Suzuki, K.; Harada, T.; Li, H.M.; Uehara, J.; Miyazaki, T.; Minami, A.; Kon, S.; Uede, T. α9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis. J. Immunol., 2009, 182(12), 8015-8025. doi: 10.4049/jimmunol.0900725 PMID: 19494327
- Goh, F.G.; Piccinini, A.M.; Krausgruber, T.; Udalova, I.A.; Midwood, K.S. Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J. Immunol., 2010, 184(5), 2655-2662. doi: 10.4049/jimmunol.0903359 PMID: 20107185
- Imanaka-Yoshida, K. Tenascin-C in cardiovascular tissue remodeling: from development to inflammation and repair. Circ. J., 2012, 76(11), 2513-2520. doi: 10.1253/circj.CJ-12-1033 PMID: 23064399
- Fu, H.; Tian, Y.; Zhou, L.; Zhou, D.; Tan, R.J.; Stolz, D.B.; Liu, Y. Tenascin-C is a major component of the fibrogenic niche in kidney fibrosis. J. Am. Soc. Nephrol., 2017, 28(3), 785-801. doi: 10.1681/ASN.2016020165 PMID: 27612995
- Siddiqui, S.; Horvat-Bröcker, A.; Faissner, A. The glia-derived extracellular matrix glycoprotein tenascin-C promotes embryonic and postnatal retina axon outgrowth via the alternatively spliced fibronectin type III domain TNfnD. Neuron Glia Biol., 2008, 4(4), 271-283. doi: 10.1017/S1740925X09990020 PMID: 19508743
- Andrews, M.R.; Czvitkovich, S.; Dassie, E.; Vogelaar, C.F.; Faissner, A.; Blits, B.; Gage, F.H.; ffrench-Constant, C.; Fawcett, J.W. α9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration. J. Neurosci., 2009, 29(17), 5546-5557. doi: 10.1523/JNEUROSCI.0759-09.2009 PMID: 19403822
- Imanaka-Yoshida, K.; Hiroe, M.; Nishikawa, T.; Ishiyama, S.; Shimojo, T.; Ohta, Y.; Sakakura, T.; Yoshida, T. Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction. Lab. Invest., 2001, 81(7), 1015-1024. doi: 10.1038/labinvest.3780313 PMID: 11454990
- Collins, A.R.; Schnee, J.; Wang, W.; Kim, S.; Fishbein, M.C.; Bruemmer, D.; Law, R.E.; Nicholas, S.; Ross, R.S.; Hsueh, W.A. Osteopontin modulates angiotensin II- induced fibrosis in the intact murine heart. J. Am. Coll. Cardiol., 2004, 43(9), 1698-1705. doi: 10.1016/j.jacc.2003.11.058 PMID: 15120833
- Settles, D.L.; Cihak, R.A.; Erickson, H.P. Tenascin-C expression in dystrophin-related muscular dystrophy. Muscle Nerve, 1996, 19(2), 147-154. doi: 10.1002/(SICI)1097-4598(199602)19:23.0.CO;2-E PMID: 8559162
- Kääriäinen, M.; Järvinen, T.; Järvinen, M.; Rantanen, J.; Kalimo, H. Relation between myofibers and connective tissue during muscle injury repair. Scand. J. Med. Sci. Sports, 2000, 10(6), 332-337. doi: 10.1034/j.1600-0838.2000.010006332.x PMID: 11085560
- Hamada, K.; Miura, Y.; Toma, N.; Miyamoto, K.; Imanaka-Yoshida, K.; Matsushima, S.; Yoshida, T.; Taki, W.; Suzuki, H. Gellan sulfate core platinum coil with tenascin-C promotes intra-aneurysmal organization in rats. Transl. Stroke Res., 2014, 5(5), 595-603. doi: 10.1007/s12975-014-0352-z PMID: 24939607
- Clark, R.A.F. Biology of dermal wound repair. Dermatol. Clin., 1993, 11(4), 647-666. doi: 10.1016/S0733-8635(18)30218-3 PMID: 8222349
- Patel, S. Danger-associated molecular patterns (DAMPs): the derivatives and triggers of inflammation. Curr. Allergy Asthma Rep., 2018, 18(11), 63. doi: 10.1007/s11882-018-0817-3 PMID: 30267163
- Liabeuf, S.; Barreto, D.V.; Kretschmer, A.; Barreto, F.C.; Renard, C.; Andrejak, M.; Choukroun, G.; Massy, Z. High circulating levels of large splice variants of tenascin-C is associated with mortality and cardiovascular disease in chronic kidney disease patients. Atherosclerosis, 2011, 215(1), 116-124. doi: 10.1016/j.atherosclerosis.2010.11.038 PMID: 21183183
- Zhu, H.; Liao, J.; Zhou, X.; Hong, X.; Song, D.; Hou, F.F.; Liu, Y.; Fu, H. Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via αvβ6 integrin signaling. Kidney Int., 2020, 97(5), 1017-1031. doi: 10.1016/j.kint.2020.01.026 PMID: 32245660
- Yasuda, M.; Harada, N.; Harada, S.; Ishimori, A.; Katsura, Y.; Itoigawa, Y.; Matsuno, K.; Makino, F.; Ito, J.; Ono, J.; Tobino, K.; Akiba, H.; Atsuta, R.; Izuhara, K.; Takahashi, K. Characterization of tenascin-C as a novel biomarker for asthma: Utility of tenascin-C in combination with periostin or immunoglobulin E. Allergy Asthma Clin. Immunol., 2018, 14(1), 72. doi: 10.1186/s13223-018-0300-7 PMID: 30473714
- Johannson, K.A.; Kolb, M.; Fell, C.D.; Assayag, D.; Fisher, J.; Churg, A. Evaluation of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society position statement; Taylor & Francis, 2017.
- Taş, İ.; Zhou, R.; Park, S.Y.; Yang, Y.; Gamage, C.D.B.; Son, Y.J.; Paik, M.J.; Kim, H. Inflammatory and tumorigenic effects of environmental pollutants found in particulate matter on lung epithelial cells. Toxicol. In Vitro, 2019, 59, 300-311. doi: 10.1016/j.tiv.2019.05.022 PMID: 31154059
- Carey, W.A.; Taylor, G.D.; Dean, W.B.; Bristow, J.D. Tenascin-C deficiency attenuates TGF-β-mediated fibrosis following murine lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol., 2010, 299(6), L785-L793. doi: 10.1152/ajplung.00385.2009 PMID: 20833777
- Clancy, P.; Lincz, L.F.; Maguire, J.; McEvoy, M.; Koblar, S.A.; Golledge, J. Tenascin-C is increased in atherothrombotic stroke patients and has an anti-inflammatory effect in the human carotid artery. Biofactors, 2014, 40(4), 448-457. doi: 10.1002/biof.1170 PMID: 24823872
- Liu, L.; Fujimoto, M.; Nakano, F.; Nishikawa, H.; Okada, T.; Kawakita, F.; Imanaka-Yoshida, K.; Yoshida, T.; Suzuki, H. Deficiency of tenascin-C alleviates neuronal apoptosis and neuroinflammation after experimental subarachnoid hemorrhage in mice. Mol. Neurobiol., 2018, 55(11), 8346-8354. doi: 10.1007/s12035-018-1006-z PMID: 29546590
- Suzuki, H.; Kanamaru, K.; Suzuki, Y.; Aimi, Y.; Matsubara, N.; Araki, T.; Takayasu, M.; Kinoshita, N.; Imanaka-Yoshida, K.; Yoshida, T.; Taki, W. Tenascin-C is induced in cerebral vasospasm after subarachnoid hemorrhage in rats and humans: A pilot study. Neurol. Res., 2010, 32(2), 179-184. doi: 10.1179/174313208X355495 PMID: 19589197
- Shiba, M.; Suzuki, H.; Fujimoto, M.; Shimojo, N.; Imanaka-Yoshida, K.; Yoshida, T.; Kanamaru, K.; Matsushima, S.; Taki, W. Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats. Neurobiol. Dis., 2012, 46(1), 172-179. doi: 10.1016/j.nbd.2012.01.005 PMID: 22300707
- Chiquet, M.; Sarasa-Renedo, A.; Tunç-Civelek, V. Induction of tenascin-C by cyclic tensile strain versus growth factors: distinct contributions by Rho/ROCK and MAPK signaling pathways. Biochim. Biophys. Acta Mol. Cell Res., 2004, 1693(3), 193-204. doi: 10.1016/j.bbamcr.2004.08.001 PMID: 15363633
- Fujimoto, M.; Shiba, M.; Kawakita, F.; Liu, L.; Shimojo, N.; Imanaka-Yoshida, K.; Yoshida, T.; Suzuki, H. Deficiency of tenascin-C and attenuation of blood-brain barrier disruption following experimental subarachnoid hemorrhage in mice. J. Neurosurg., 2016, 124(6), 1693-1702. doi: 10.3171/2015.4.JNS15484 PMID: 26473781
- Cho, A.; Graves, J.; Reidy, M.A. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 2000, 20(12), 2527-2532. doi: 10.1161/01.ATV.20.12.2527 PMID: 11116048
- Okada, T.; Suzuki, H. Mechanisms of neuroinflammation and inflammatory mediators involved in brain injury following subarachnoid hemorrhage. Histol. Histopathol., 2020, 35(7), 623-636. PMID: 32026458
- Hendryk, S.; Jarzab, B.; Josko, J. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuroendocrinol. Lett., 2004, 25(1-2), 141-147. PMID: 15159698
- Suzuki, K.; Meguro, K.; Sakurai, T.; Saitoh, Y.; Takeuchi, S.; Nose, T. Endothelin-1 concentration increases in the cerebrospinal fluid in cerebral vasospasm caused by subarachnoid hemorrhage. Surg. Neurol., 2000, 53(2), 131-135. doi: 10.1016/S0090-3019(99)00179-2 PMID: 10713190
- Okada, T.; Kawakita, F.; Nishikawa, H.; Nakano, F.; Liu, L.; Suzuki, H. Selective toll-like receptor 4 antagonists prevent acute blood-brain barrier disruption after subarachnoid hemorrhage in mice. Mol. Neurobiol., 2019, 56(2), 976-985. doi: 10.1007/s12035-018-1145-2 PMID: 29855971
- Suzuki, H.; Fujimoto, M.; Kawakita, F.; Liu, L.; Nakatsuka, Y.; Nakano, F.; Nishikawa, H.; Okada, T.; Kanamaru, H.; Imanaka-Yoshida, K.; Yoshida, T.; Shiba, M. Tenascin-C in brain injuries and edema after subarachnoid hemorrhage: Findings from basic and clinical studies. J. Neurosci. Res., 2020, 98(1), 42-56. doi: 10.1002/jnr.24330 PMID: 30242870
- Suzuki, H.; Okada, T. Toll-like receptor 4 as a possible therapeutic target for delayed brain injuries after aneurysmal subarachnoid hemorrhage. Neural Regen. Res., 2017, 12(2), 193-196. doi: 10.4103/1673-5374.200795 PMID: 28400792
- Fujimoto, M.; Shiba, M.; Kawakita, F.; Liu, L.; Shimojo, N.; Imanaka-Yoshida, K.; Yoshida, T.; Suzuki, H. Effects of tenascin-C knockout on cerebral vasospasm after experimental subarachnoid hemorrhage in mice. Mol. Neurobiol., 2018, 55(3), 1951-1958. doi: 10.1007/s12035-017-0466-x PMID: 28244007
Supplementary files
